Join our newsletter. Sign up today


Publications and related articles about Lunaphore Technologies and the industry in general.

Lunaphore and Epredia announce agreement for exclusive distribution of LabSat® Research

We are happy to announce that we have entered into a distribution agreement with Epredia, a global leader in precision cancer diagnostics and tissue diagnostics.

Under the terms of this agreement, Epredia have been appointed the exclusive distributor of the LabSat® Research platform in the US, UK and Germany, where Epredia will start to distribute the product in July 2020, as well as Japan, where the commercialization will begin in 2021.

Read the full press release

Categories: Press Releases

Share this

Hi! We use cookies to improve this website. By continuing to use our services, you are giving us your consent to use cookies. Learn more about our privacy policy and our terms of use.
I agree